Work

Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior

Year: 2021

Type: article

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2021.04.024

Authors: Briana K. Chen, Victor M. Luna, Margaret E. Shannon, Holly C. Hunsberger, Alessia Mastrodonato, Michelle Stackmann, Josephine C. McGowan, Gilles Rubinstenn, Christine A. Denny

Institutions: Columbia University, Columbia University Irving Medical Center, Research Foundation For Mental Hygiene, New York State Psychiatric Institute

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Columbia University, National Institute on Aging, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: The PACAP signaling pathway as a novel regulator of the neural circuits underlying fear generalization, The Impact of Increasing Neurogenesis on Cognitive Deficits Related to Aging, Translational Neuroscience Training Grant., Identification and manipulation of the neural ensembles mediating sundowning in an Alzheimer's disease mouse model, Identification and Pharmacological Manipulation of Fear Overgeneralization Neural Ensembles following Traumatic Brain Injury (TBI), Single-cell and target-specific resolution of multiple memories across the brain, Identification and manipulation of whole-brain memory traces following age-related cognitive decline or Alzheimer's disease, Dissecting the role of Arc- and c-fos-expressing neuronal ensembles in fear memories

OpenAlex ID: W3161528957

FWCI: 1.855

Cites: 75

Cited by: 24

Related to: 10